Laboratories that perform cell-based methods must meet stringent GMP guidelines for analytical procedures. In addition, standard operating procedures that specifically address working with cells should be in place to maintain control of a live assay system. GMP inspections should cover additional topics in cell-based laboratories to confirm procedures are sound from a regulatory perspective.
Cell-based laboratories are responsible for analytical data for biopharmaceutical products. Included in this analysis are cell-based methods that determine the potency of the product. This webinar will discuss key points to assess during the preparation and performance of GMP laboratory inspections/audits. Included in this presentation are suggestions for specific items to review and negotiating changes to procedures. The quality or laboratory professional that attends this webinar will gain knowledge useful in addressing maintaining a quality method in a cell-based laboratory.
Course Objective:
• Regulatory agency expectations
• Identifying additional audit/inspection topics specific for cell-based laboratories
• Establishing and communicating the audit plan
• Identifying the audit team
• Assessments during the walk-throughs
• Setting the timing
• Identifying potential quality issues
• Presenting findings
• Negotiating responses
Course Outline:
Topics covered includes:
• Brief overview of FDA and EMEA Guidelines
• Establishing objectives of the audit/inspection
• Identifying the audit team
• Review of quality agreement(s)
• Preparing the audit/inspection plan
• Key systems to review
• Key SOPs to review
• Understanding the impact of differences
• Setting the timing and the agenda
• Communicating findings
• Follow-up and closure of the audit/inspection
What You Get:
• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
• Compliance Professionals
• Validation Scientists
• Quality Assurance
• Quality Control
• Regulatory Affairs
• Laboratory Managers
• Assay Development Specialists
Auditing Quality Suppliers and Vendors
Get Instant Access 90 Minutes View Program |
Understanding the FDA Compounding Pharmacies Guidance
Get Instant Access 60 Minutes View Program |
Vendor Qualification - Evaluating Vendors & Understanding their Capabilities
Get Instant Access 60 Minutes View Program |
Drug Pharmacy Compounding
Get Instant Access 60 Minutes View Program |
GMP Requirements for Records and Reports
Get Instant Access 90 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry